The role of Interleukin-33 in the modulation of splenic T-cell immune responses after experimental ischemic stroke
Authors:
- 1 August 2019
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 333, 576970
Abstract
No abstract availableKeywords
Funding Information
- National Nature Science Foundation of China (81501033)
- Fundamental Research Funds for the Central Universities (2042015kf0099)
This publication has 50 references indexed in Scilit:
- Importance of T Lymphocytes in Brain Injury, Immunodeficiency, and Recovery after Cerebral IschemiaJournal of Cerebral Blood Flow & Metabolism, 2012
- Production and functions of IL-33 in the central nervous systemBrain Research, 2011
- A role for spleen monocytes in post-ischemic brain inflammation and injuryJournal of Neuroinflammation, 2010
- IL-33 family members and asthma – bridging innate and adaptive immune responsesCurrent Opinion in Immunology, 2010
- Inflammatory mechanisms in ischemic stroke: role of inflammatory cellsJournal of Leukocyte Biology, 2010
- Inflammatory mechanisms in ischemic stroke: therapeutic approachesJournal of Translational Medicine, 2009
- Blockade of adrenoreceptors inhibits the splenic response to strokeExperimental Neurology, 2009
- RETRACTED: The cytokine interleukin-33 mediates anaphylactic shockProceedings of the National Academy of Sciences, 2009
- The spleen contributes to stroke‐induced neurodegenerationJournal of Neuroscience Research, 2008
- IL-33 reduces the development of atherosclerosisJournal of Experimental Medicine, 2008